 Cholecystokinin growth human pancreatic adenocarcinoma effect synthetic analogue CCK growth human pancreatic cancer experimental models Nude mice pancreatic cancer xenografts CCK micrograms/kg vehicle days Animals tumor volume weight protein deoxyribonucleic acid DNA content cells vitro effects CCK secretin vasoactive intestinal peptide VIP proglumide CCK-receptor antagonist cell number DNA synthesis dose CCK micrograms/kg tumor weight protein content DNA content vitro CCK significant increases cell counts days days Graded concentrations CCK biphasic effect DNA synthesis significant increases CCK-induced cell proliferation proglumide Secretin cancer cell growth CCK VIP secretin combination CCK potentiation results growth human pancreatic cancers gastrointestinal peptides CCK potent